337 related articles for article (PubMed ID: 28185960)
1. Lipid nanovehicles with adjustable surface properties for overcoming multiple barriers simultaneously in oral administration.
Wu L; Liu M; Shan W; Cui Y; Zhang Z; Huang Y
Int J Pharm; 2017 Mar; 520(1-2):216-227. PubMed ID: 28185960
[TBL] [Abstract][Full Text] [Related]
2. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
[TBL] [Abstract][Full Text] [Related]
3. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
[TBL] [Abstract][Full Text] [Related]
4. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
[TBL] [Abstract][Full Text] [Related]
5. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
[TBL] [Abstract][Full Text] [Related]
6. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
[TBL] [Abstract][Full Text] [Related]
7. Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics.
Guo S; Liang Y; Liu L; Yin M; Wang A; Sun K; Li Y; Shi Y
J Nanobiotechnology; 2021 Jan; 19(1):32. PubMed ID: 33499885
[TBL] [Abstract][Full Text] [Related]
8. Polymer-functionalized mesoporous carbon nanoparticles on overcoming multiple barriers and improving oral bioavailability of Probucol.
Lu H; Yang G; Ran F; Gao T; Sun C; Zhao Q; Wang S
Carbohydr Polym; 2020 Feb; 229():115508. PubMed ID: 31826471
[TBL] [Abstract][Full Text] [Related]
9. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery.
Iglesias T; López de Cerain A; Irache JM; Martín-Arbella N; Wilcox M; Pearson J; Azqueta A
Int J Pharm; 2017 Jan; 517(1-2):67-79. PubMed ID: 27908629
[TBL] [Abstract][Full Text] [Related]
11. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
[TBL] [Abstract][Full Text] [Related]
12. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs.
Wu L; Liu M; Shan W; Zhu X; Li L; Zhang Z; Huang Y
J Control Release; 2017 Sep; 262():273-283. PubMed ID: 28774842
[TBL] [Abstract][Full Text] [Related]
13. Cellular uptake and transcytosis of lipid-based nanoparticles across the intestinal barrier: Relevance for oral drug delivery.
Neves AR; Queiroz JF; Costa Lima SA; Figueiredo F; Fernandes R; Reis S
J Colloid Interface Sci; 2016 Feb; 463():258-65. PubMed ID: 26550783
[TBL] [Abstract][Full Text] [Related]
14. Functional lipid polymeric nanoparticles for oral drug delivery: Rapid mucus penetration and improved cell entry and cellular transport.
Liu Y; Jiang Z; Hou X; Xie X; Shi J; Shen J; He Y; Wang Z; Feng N
Nanomedicine; 2019 Oct; 21():102075. PubMed ID: 31377378
[TBL] [Abstract][Full Text] [Related]
15. Oral In-Situ Nanoplatform with Balanced Hydrophobic-Hydrophilic Property for Transport Across Gastrointestinal Mucosa.
Attar ES; Jayakumar S; Devarajan PV
AAPS PharmSciTech; 2024 May; 25(5):113. PubMed ID: 38750336
[TBL] [Abstract][Full Text] [Related]
16. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.
Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y
ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398
[TBL] [Abstract][Full Text] [Related]
17. Cell-penetrating peptide together with PEG-modified mesostructured silica nanoparticles promotes mucous permeation and oral delivery of therapeutic proteins and peptides.
Tan X; Zhang Y; Wang Q; Ren T; Gou J; Guo W; Yin T; He H; Zhang Y; Tang X
Biomater Sci; 2019 Jun; 7(7):2934-2950. PubMed ID: 31094367
[TBL] [Abstract][Full Text] [Related]
18. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.
Fan W; Xia D; Zhu Q; Li X; He S; Zhu C; Guo S; Hovgaard L; Yang M; Gan Y
Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774
[TBL] [Abstract][Full Text] [Related]
19. Core-shell stability of nanoparticles plays an important role for overcoming the intestinal mucus and epithelium barrier.
Liu M; Wu L; Zhu X; Shan W; Li L; Cui Y; Huang Y
J Mater Chem B; 2016 Sep; 4(35):5831-5841. PubMed ID: 32263756
[TBL] [Abstract][Full Text] [Related]
20. Designing nanoparticle translocation through cell membranes by varying amphiphilic polymer coatings.
Zhang L; Becton M; Wang X
J Phys Chem B; 2015 Mar; 119(9):3786-94. PubMed ID: 25675048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
